MignotE. Narcolepsy: pharmacology, pathophysiology, and genetics. In: KrygerMHRothTDementWC, eds. Principles and Practice of Sleep Medicine. Philadelphia, PA: Elsevier; 2005:761-779.
2.
GuilleminaultCFromherzS. Narcolepsy diagnosis and management. In: KrygerMHRothTDementWC, eds. Principles and Practice of Sleep Medicine. Philadelphia, PA: Elsevier; 2005:780-789.
3.
NevsimalovaS. Narcolepsy in childhood. Sleep Med Rev. 2009;13:169-180. doi:10.1016/j.smrv.2008.04.007.
4.
DauvilliersYArnulfIMignotE. Narcolepsy with cataplexy. Lancet. 2007;369:499-511.
5.
ThannickalTC. A decade of hypocretin/orexin: accomplishments in sleep medicine. Sleep Med Rev. 2009;13:5-8. doi:10.1016/j.smrv.2008.09.004.
6.
LongstrethWTJrKoepsellTDTonTGHendricksonAFvan BelleG. The epidemiology of narcolepsy. Sleep. 2007;30:13-26.
7.
PeyronCFaracoJRogersW. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6:991-997.
8.
MorgenthalerTIKapurVKBrownT; Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30:1705-1711.
9.
SakuraiT. Orexin deficiency and narcolepsy. Curr Opin Neurobiol. 2013;23:760-766. doi:10.1016/j.conb.2013.04.007.
10.
ChabasDTaheriSRenierCMignotE. The genetics of narcolepsy. Annu Rev Genomics Hum Genet. 2003;4:459-483.
11.
MignotE. Genetic and familial aspects of narcolepsy. Neurology. 1998;50:S16-S22.
12.
WatsonNFTonTGKoepsellTDGersukVHLongstrethWTJr. Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status?Sleep. 2010;33:29-35.
13.
LongstrethWTJrTonTGKoepsellTD. Narcolepsy and streptococcal infections. Sleep. 2009;32:1548.
14.
NatarajanNJainSVChaudhryHHallinanBESimakajornboonN. Narcolepsy-cataplexy: is streptococcal infection a trigger?J Clin Sleep Med. 2013;9:269-270. doi:10.5664/jcsm.2498.
15.
KornumBRFaracoJMignotE. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol. 2011;21:897-903. doi:10.1016/j.conb.2011.09.003.
16.
DelaHerrán-AritaAKKornumBRMahliosJ. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Transl Med. 2013;5:216 ra176. doi:10.1126/scitranslmed.3007762.
17.
AranALinLNevsimalovaS. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep. 2009;32:979-983.
18.
HanFLinLWarbySC. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol. 2011;70:410-417. doi:10.1002/ana.22587.
19.
HeierMSGautvikKMWannagE. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med. 2013;14:867-871. doi:10.1016/j.sleep.2013.03.020.
20.
PartinenMSaarenpää-HeikkiläOIlveskoskiI. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 2012;7:e33723.
21.
DauvilliersYArnulfILecendreuxM; Narcoflu-VF Study Group. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain. 2013;136:2486-2496. doi:10.1093/brain/awt187.
22.
SerraLMontagnaPMignotELugaresiEPlazziG. Cataplexy features in childhood narcolepsy. Mov Disord. 2008;23:858-865. doi:10.1002/mds.21965.
23.
NevsimalovaSPiskoJBuskovaJ. Narcolepsy: clinical differences and association with other sleep disorders in different age groups. J Neurol. 2013;260:767-775. doi:10.1007/s00415-012-6702-4.
24.
KotagalSKumarS. Childhood onset narcolepsy cataplexy-more than just a sleep disorder. Sleep. 2013;36:161-162. doi:10.5665/sleep.2358.
25.
PizzaFFranceschiniCPeltolaH. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain. 2013;136:3787-3795. doi:10.1093/brain/awt277.
26.
PizzaFVandiSPoliF. Narcolepsy with cataplexy mimicry: the strange case of two sisters. J Clin Sleep Med. 2013;9:611-622. doi:10.5664/jcsm.2764.
27.
PosarAPizzaFParmeggianiAPlazziG. Neuropsychological findings in childhood narcolepsy [published online November 28, 2013]. J Child Neurol. doi:10.1177/0883073813508315.
28.
OhayonMM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med. 2013;14:488-492. doi:10.1016/j.sleep.2013.03.002.
29.
InocenteCOLavaultSLecendreuxM. Impact of obesity in children with narcolepsy. CNS Neurosci Ther. 2013;19:521-528. doi:10.1111/cns.12105.
30.
FrauscherBEhrmannLMitterlingT. Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the Innsbruck Narcolepsy Cohort. J Clin Sleep Med. 2013;9:805-812. doi:10.5664/jcsm.2926.
JambhekarSKComGJonesE. Periodic limb movements during sleep in children with narcolepsy. J Clin Sleep Med. 2011;7:597-601. doi:10.5664/jcsm.1458.
33.
AldrichMSChervinRDMalowBA. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep. 1997;20:620-629.
34.
SinsiocoCSilverKForrestKM. Narcolepsy with cataplexy as presenting symptom of occult neuroblastoma. Pediatr Neurol. 2013;49:64-67. doi:10.1016/j.pediatrneurol.2012.12.038.
35.
Dang-VuTT. Neuroimaging findings in narcolepsy with cataplexy. Curr Neurol Neurosci Rep. 2013;13:349. doi:10.1007/s11910-013-0349-0.
36.
LittnerMJohnsonSFMcCallWV; Standards of Practice Committee. Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep. 2001;24:451-466.
37.
WiseMSArandDLAugerRRBrooksSNWatsonNF; American Academy of Sleep Medicine. Treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30:1712-1727.
38.
BilliardM. Narcolepsy: current treatment options and future approaches. Neuropsychiatr Dis Treat. 2008;4:557-566.
39.
MignotE. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics. 2012;9:739-752. doi:10.1007/s13311-012-0150-9.
40.
HiraiNNishinoS. Recent advances in the treatment of narcolepsy. Curr Treat Options Neurol. 2011;13:437-457. doi:10.1007/s11940-011-0137-6.
41.
LavaultSDauvilliersYDrouotX. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. Sleep Med. 2011;12:550-556. doi:10.1016/j.sleep.2011.03.010.
42.
BeusterienKMRogersAEWalslebenJA. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep. 1999;22:757-765.
43.
FraseLSchuppJSorichterSRandelshoferWRiemannDNissenC. Sodium oxybate-induced central sleep apneas. Sleep Med. 2013;14:922-924. doi:10.1016/j.sleep.2013.03.023.
44.
MansukhaniMPKotagalS. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study. Sleep Med. 2012;13:606-610. doi:10.1016/j.sleep.2011.10.032.
45.
LammersGJBassettiCBilliardM. Sodium oxybate is an effective and safe treatment for narcolepsy. Sleep Med. 2010;11:105-106. doi:10.1016/j.sleep.2009.08.003.
46.
AranAEinenMLinLPlazziGNishinoSMignotE. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep. 2010;33:1457-1464.
47.
DauvilliersYAbrilBMasEMichelFTaftiM. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology. 2009;73:1333-1334.
